The Global Colon Cancer Association (GCCA) works with members and in collaboration with partners and stakeholders that share its commitment to patient-centered healthcare.
The GCCA advocates for patient-centered policies, increased education and advocacy related to screening, innovation in diagnostics and treatment, and access to safe and effective therapies. The Association has been an active voice in the patient, healthcare, and regulatory communities on issues that are important to patients. It has represented the bowel cancer patients at all levels of government, including the World Health Organisation, United Nations and US Food and Drug Admnistration (FDA).
The GCCA represents more than 40 patient member organisations.